Prof. dr. R.O. Schlingemann
1 clinical trials · Sponsor
◉ Watch Prof. dr. R.O. Schlingemann
| Record | Firm | Date |
|---|---|---|
| Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) (NCT01635790) | Prof. dr. R.O. Schlingemann | 2012-06-01 |
Track Prof. dr. R.O. Schlingemann automatically
Every clearance here is in the API, with alerts when new ones post.